Follow the 立方制药 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 立方制药 has logged 11 insider filings. Market capitalisation: €3.8bn. The latest transaction was disclosed on 21 June 2023 (Sale). Among the most active insiders: 汪琴. The full history is openly available.
11
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€539,404
11 ops.
Sell Volume
11Σ signal
Buys n/a€539,404 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,245 of 29,062 companies
62.2
score / 100
Value
51
Quality
73
FCF yld2.5%
Earn yld4.4%
EV/EBITDA14.1x
ROE8.1%
Gross mgn65%
Net mgn11%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.